Logo image of COUR

COURSERA INC (COUR) Stock Fundamental Analysis

NYSE:COUR - New York Stock Exchange, Inc. - US22266M1045 - Common Stock - Currency: USD

8.43  +0.14 (+1.69%)

After market: 8.43 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to COUR. COUR was compared to 71 industry peers in the Diversified Consumer Services industry. No worries on liquidiy or solvency for COUR as it has an excellent financial health rating, but there are worries on the profitability. COUR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year COUR was profitable.
In the past year COUR had a positive cash flow from operations.
In the past 5 years COUR always reported negative net income.
In multiple years COUR reported negative operating cash flow during the last 5 years.
COUR Yearly Net Income VS EBIT VS OCF VS FCFCOUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

The Return On Assets of COUR (-6.95%) is comparable to the rest of the industry.
COUR's Return On Equity of -10.82% is in line compared to the rest of the industry. COUR outperforms 49.30% of its industry peers.
Industry RankSector Rank
ROA -6.95%
ROE -10.82%
ROIC N/A
ROA(3y)-13.24%
ROA(5y)-14.17%
ROE(3y)-19.16%
ROE(5y)-20.97%
ROIC(3y)N/A
ROIC(5y)N/A
COUR Yearly ROA, ROE, ROICCOUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

With a decent Gross Margin value of 53.88%, COUR is doing good in the industry, outperforming 67.61% of the companies in the same industry.
COUR's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for COUR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.81%
GM growth 5Y0.79%
COUR Yearly Profit, Operating, Gross MarginsCOUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

7

2. Health

2.1 Basic Checks

COUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, COUR has more shares outstanding
COUR has more shares outstanding than it did 5 years ago.
There is no outstanding debt for COUR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
COUR Yearly Shares OutstandingCOUR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
COUR Yearly Total Debt VS Total AssetsCOUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

COUR has an Altman-Z score of 2.20. This is not the best score and indicates that COUR is in the grey zone with still only limited risk for bankruptcy at the moment.
COUR has a Altman-Z score (2.20) which is in line with its industry peers.
COUR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.2
ROIC/WACCN/A
WACC9.02%
COUR Yearly LT Debt VS Equity VS FCFCOUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

COUR has a Current Ratio of 2.55. This indicates that COUR is financially healthy and has no problem in meeting its short term obligations.
COUR has a better Current ratio (2.55) than 76.06% of its industry peers.
A Quick Ratio of 2.55 indicates that COUR has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.55, COUR is in the better half of the industry, outperforming 77.46% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.55
Quick Ratio 2.55
COUR Yearly Current Assets VS Current LiabilitesCOUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

5

3. Growth

3.1 Past

COUR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 230.51%, which is quite impressive.
Looking at the last year, COUR shows a small growth in Revenue. The Revenue has grown by 7.27% in the last year.
Measured over the past years, COUR shows a very strong growth in Revenue. The Revenue has been growing by 30.38% on average per year.
EPS 1Y (TTM)230.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%71.43%
Revenue 1Y (TTM)7.27%
Revenue growth 3Y18.71%
Revenue growth 5Y30.38%
Sales Q2Q%6.05%

3.2 Future

Based on estimates for the next years, COUR will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.90% on average per year.
COUR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.70% yearly.
EPS Next Y5%
EPS Next 2Y12.82%
EPS Next 3Y13.9%
EPS Next 5YN/A
Revenue Next Year5.02%
Revenue Next 2Y4.95%
Revenue Next 3Y4.7%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
COUR Yearly Revenue VS EstimatesCOUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
COUR Yearly EPS VS EstimatesCOUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 21.62, the valuation of COUR can be described as rather expensive.
Based on the Price/Earnings ratio, COUR is valued a bit cheaper than 69.01% of the companies in the same industry.
COUR's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.65.
Based on the Price/Forward Earnings ratio of 19.48, the valuation of COUR can be described as rather expensive.
Based on the Price/Forward Earnings ratio, COUR is valued a bit cheaper than 64.79% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.27. COUR is around the same levels.
Industry RankSector Rank
PE 21.62
Fwd PE 19.48
COUR Price Earnings VS Forward Price EarningsCOUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of COUR indicates a somewhat cheap valuation: COUR is cheaper than 73.24% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 20.47
EV/EBITDA N/A
COUR Per share dataCOUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as COUR's earnings are expected to grow with 13.90% in the coming years.
PEG (NY)4.32
PEG (5Y)N/A
EPS Next 2Y12.82%
EPS Next 3Y13.9%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for COUR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COURSERA INC

NYSE:COUR (6/23/2025, 8:04:00 PM)

After market: 8.43 0 (0%)

8.43

+0.14 (+1.69%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)04-24 2025-04-24/amc
Earnings (Next)07-23 2025-07-23/amc
Inst Owners78.95%
Inst Owner Change0.33%
Ins Owners6.6%
Ins Owner Change1.71%
Market Cap1.36B
Analysts74.29
Price Target10.03 (18.98%)
Short Float %3.03%
Short Ratio2.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)71.06%
Min EPS beat(2)49.74%
Max EPS beat(2)92.38%
EPS beat(4)4
Avg EPS beat(4)292.01%
Min EPS beat(4)49.74%
Max EPS beat(4)669.94%
EPS beat(8)8
Avg EPS beat(8)1337.63%
EPS beat(12)11
Avg EPS beat(12)907.01%
EPS beat(16)14
Avg EPS beat(16)686.13%
Revenue beat(2)1
Avg Revenue beat(2)-0.13%
Min Revenue beat(2)-0.48%
Max Revenue beat(2)0.22%
Revenue beat(4)2
Avg Revenue beat(4)0.13%
Min Revenue beat(4)-0.77%
Max Revenue beat(4)1.57%
Revenue beat(8)5
Avg Revenue beat(8)0.52%
Revenue beat(12)8
Avg Revenue beat(12)0.64%
Revenue beat(16)11
Avg Revenue beat(16)1.18%
PT rev (1m)0.85%
PT rev (3m)-0.42%
EPS NQ rev (1m)0.84%
EPS NQ rev (3m)3.08%
EPS NY rev (1m)0.2%
EPS NY rev (3m)-6.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.89%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.69%
Valuation
Industry RankSector Rank
PE 21.62
Fwd PE 19.48
P/S 1.93
P/FCF 20.47
P/OCF 13.03
P/B 2.23
P/tB 2.32
EV/EBITDA N/A
EPS(TTM)0.39
EY4.63%
EPS(NY)0.43
Fwd EY5.13%
FCF(TTM)0.41
FCFY4.89%
OCF(TTM)0.65
OCFY7.67%
SpS4.37
BVpS3.78
TBVpS3.63
PEG (NY)4.32
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.95%
ROE -10.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.88%
FCFM 9.43%
ROA(3y)-13.24%
ROA(5y)-14.17%
ROE(3y)-19.16%
ROE(5y)-20.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.81%
GM growth 5Y0.79%
F-Score7
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 146.91%
Cap/Sales 5.38%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.55
Quick Ratio 2.55
Altman-Z 2.2
F-Score7
WACC9.02%
ROIC/WACCN/A
Cap/Depr(3y)108%
Cap/Depr(5y)109.75%
Cap/Sales(3y)3.84%
Cap/Sales(5y)3.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)230.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%71.43%
EPS Next Y5%
EPS Next 2Y12.82%
EPS Next 3Y13.9%
EPS Next 5YN/A
Revenue 1Y (TTM)7.27%
Revenue growth 3Y18.71%
Revenue growth 5Y30.38%
Sales Q2Q%6.05%
Revenue Next Year5.02%
Revenue Next 2Y4.95%
Revenue Next 3Y4.7%
Revenue Next 5YN/A
EBIT growth 1Y30.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year211.42%
EBIT Next 3Y71.4%
EBIT Next 5YN/A
FCF growth 1Y794.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2030.84%
OCF growth 3Y279.12%
OCF growth 5YN/A